MATTHEW W TOWSE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW W TOWSE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W TOWSE. MATTHEW W TOWSE is Senior Vice President in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and Senior Vice President, CFO in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and Sr VP, CFO in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and SVP and Chief Financial Office in NxStage Medical, Inc. ($NXTM).
Latest Insider Trading Transactions of MATTHEW W TOWSE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2018 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 0.00 | 5,821 | 0 | 11,643 | |
Mar 12 2018 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | A | 0.00 | 17,464 | 0 | 17,464 | |
Mar 12 2018 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 24.37 | 1,846 | 44,987 | 28,396 | 30.2 K to 28.4 K (-6.10 %) |
Mar 12 2018 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 0.00 | 5,821 | 0 | 30,242 | 24.4 K to 30.2 K (+23.84 %) |
Oct 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,030 | 56,622 | 0 | |
Oct 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 27.50 | 4,030 | 110,825 | 24,421 | 28.5 K to 24.4 K (-14.16 %) |
Oct 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,030 | 56,622 | 28,451 | 24.4 K to 28.5 K (+16.50 %) |
Sep 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 4,030 | |
Sep 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 27.27 | 4,300 | 117,261 | 24,421 | 28.7 K to 24.4 K (-14.97 %) |
Sep 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 28,721 | 24.4 K to 28.7 K (+17.61 %) |
Aug 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 8,330 | |
Aug 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 29.22 | 4,300 | 125,646 | 24,421 | 28.7 K to 24.4 K (-14.97 %) |
Aug 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 28,721 | 24.4 K to 28.7 K (+17.61 %) |
Jul 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 12,630 | |
Jul 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 24.16 | 4,300 | 103,888 | 24,421 | 28.7 K to 24.4 K (-14.97 %) |
Jul 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 28,721 | 24.4 K to 28.7 K (+17.61 %) |
Jul 17 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 24.28 | 916 | 22,240 | 24,421 | 25.3 K to 24.4 K (-3.62 %) |
Jun 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 16,930 | |
Jun 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 23.29 | 4,300 | 100,147 | 25,337 | 29.6 K to 25.3 K (-14.51 %) |
Jun 21 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 29,637 | 25.3 K to 29.6 K (+16.97 %) |
May 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 21,230 | |
May 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 21.36 | 4,300 | 91,848 | 25,337 | 29.6 K to 25.3 K (-14.51 %) |
May 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 29,637 | 25.3 K to 29.6 K (+16.97 %) |
Apr 20 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 25,530 | |
Apr 20 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 27.28 | 4,300 | 117,304 | 25,337 | 29.6 K to 25.3 K (-14.51 %) |
Apr 20 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 29,637 | 25.3 K to 29.6 K (+16.97 %) |
Mar 22 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 29,830 | |
Mar 22 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 27.66 | 4,300 | 118,938 | 25,337 | 29.6 K to 25.3 K (-14.51 %) |
Mar 22 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 29,637 | 25.3 K to 29.6 K (+16.97 %) |
Mar 13 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | A | 27.89 | 49,855 | 1,390,456 | 49,855 | |
Mar 06 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 0.00 | 9,747 | 0 | 0 | |
Mar 06 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 28.31 | 3,151 | 89,205 | 25,337 | 28.5 K to 25.3 K (-11.06 %) |
Mar 06 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 0.00 | 9,747 | 0 | 28,488 | 18.7 K to 28.5 K (+52.01 %) |
Feb 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 34,130 | |
Feb 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 29.26 | 4,300 | 125,818 | 18,741 | 23 K to 18.7 K (-18.66 %) |
Feb 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 23,041 | 18.7 K to 23 K (+22.94 %) |
Jan 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 38,430 | |
Jan 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 26.19 | 4,300 | 112,617 | 18,741 | 23 K to 18.7 K (-18.66 %) |
Jan 23 2017 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 23,041 | 18.7 K to 23 K (+22.94 %) |
Dec 20 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 42,730 | |
Dec 20 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 25.55 | 4,300 | 109,865 | 18,741 | 23 K to 18.7 K (-18.66 %) |
Dec 20 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 23,041 | 18.7 K to 23 K (+22.94 %) |
Nov 21 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 4,300 | 60,415 | 47,030 | |
Nov 21 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 26.23 | 4,300 | 112,789 | 18,741 | 23 K to 18.7 K (-18.66 %) |
Nov 21 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 4,300 | 60,415 | 23,041 | 18.7 K to 23 K (+22.94 %) |
Jul 18 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 21.73 | 688 | 14,950 | 18,741 | 19.4 K to 18.7 K (-3.54 %) |
Mar 10 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | A | 15.58 | 89,386 | 1,392,634 | 89,386 | |
Mar 07 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 0.00 | 9,746 | 0 | 9,747 | |
Mar 07 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 15.48 | 3,264 | 50,527 | 19,429 | 22.7 K to 19.4 K (-14.38 %) |
Mar 07 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 0.00 | 9,746 | 0 | 22,693 | 12.9 K to 22.7 K (+75.28 %) |
Jan 11 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 3,472 | 48,782 | 51,330 | |
Jan 11 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 20.40 | 3,472 | 70,829 | 12,947 | 16.4 K to 12.9 K (-21.15 %) |
Jan 11 2016 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 3,472 | 48,782 | 16,419 | 12.9 K to 16.4 K (+26.82 %) |
Dec 17 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 2,863 | 40,225 | 54,802 | |
Dec 17 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 19.51 | 2,863 | 55,857 | 12,947 | 15.8 K to 12.9 K (-18.11 %) |
Dec 17 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 2,863 | 40,225 | 15,810 | 12.9 K to 15.8 K (+22.11 %) |
Nov 12 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 2,863 | 40,225 | 57,665 | |
Nov 12 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 20.32 | 2,863 | 58,176 | 12,947 | 15.8 K to 12.9 K (-18.11 %) |
Nov 12 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 2,863 | 40,225 | 15,810 | 12.9 K to 15.8 K (+22.11 %) |
Nov 04 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 14.05 | 8,591 | 120,704 | 60,528 | |
Nov 04 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 19.50 | 8,591 | 167,525 | 12,947 | 21.5 K to 12.9 K (-39.89 %) |
Nov 04 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 14.05 | 8,591 | 120,704 | 21,538 | 12.9 K to 21.5 K (+66.36 %) |
Aug 10 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Sell | S | 15.52 | 5,455 | 84,662 | 12,947 | 18.4 K to 12.9 K (-29.64 %) |
Jul 17 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 14.44 | 459 | 6,628 | 18,402 | 18.9 K to 18.4 K (-2.43 %) |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | M | 0.00 | 9,746 | 0 | 19,493 | |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | A | 0.00 | 29,239 | 0 | 29,239 | |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Option Exercise | A | 16.66 | 65,618 | 1,093,196 | 65,618 | |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Payment of Exercise | F | 16.66 | 3,162 | 52,679 | 18,861 | 22 K to 18.9 K (-14.36 %) |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Buy | M | 0.00 | 9,746 | 0 | 22,023 | 12.3 K to 22 K (+79.38 %) |
Mar 05 2015 | NXTM | NxStage Medical, I ... | TOWSE MATTHEW W | SVP and Chief Finan ... | Grant | A | 16.66 | 5,455 | 90,880 | 12,277 | 6.8 K to 12.3 K (+79.96 %) |
Jul 19 2005 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Senior Vice Preside ... | Option Exercise | A | 0.00 | 3,334 | 0 | 3,334 | |
Jul 19 2005 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Senior Vice Preside ... | Option Exercise | A | 15.91 | 10,000 | 159,100 | 10,000 | |
May 06 2005 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Sr VP, CFO | Option Exercise | M | 0.00 | 963 | 0 | 2,887 | |
May 06 2005 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Sr VP, CFO | Sell | S | 13.94 | 292 | 4,070 | 6,778 | 7.1 K to 6.8 K (-4.13 %) |
May 06 2005 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Sr VP, CFO | Buy | M | 0.00 | 963 | 0 | 7,070 | 6.1 K to 7.1 K (+15.77 %) |
May 06 2004 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Senior Vice Preside ... | Option Exercise | A | 0.00 | 3,850 | 0 | 3,850 | |
May 06 2004 | FCS | FAIRCHILD SEMICOND ... | TOWSE MATTHEW W | Senior Vice Preside ... | Option Exercise | A | 19.65 | 25,050 | 492,233 | 25,050 |
Page: 1